Bone Neoplasm, Benign
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery (NCT02293031) | NextGen Company Limited | 2014-11-01 |
Track Bone Neoplasm, Benign automatically
Every clearance here is in the API, with alerts when new ones post.